Association between dihydropyridine calcium channel blockers and ischemic strokes in patients with nonvalvular atrial fibrillation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-02-17

AUTHORS

Fumihiro Sakakibara, Shinichiro Ueda, Kazutaka Uchida, Norito Kinjo, Hideki Arai, Mari Nezu, Takeshi Morimoto

ABSTRACT

Outside of clinical trials, the prophylactic effect of dihydropyridine calcium channel blockers (CCBs) on ischemic events in patients with nonvalvular atrial fibrillation (NVAF) has not been confirmed. We compared the effect of dihydropyridine CCBs on ischemic events in anticoagulated NVAF patients. We conducted a multicenter historical cohort study at 71 centers in Japan. The inclusion criterion was taking vitamin K antagonists for NVAF. The exclusion criteria were mechanical heart valves and a history of pulmonary thrombosis or deep vein thrombosis. Consecutive patients (N = 7826) were registered in February 2013 and were followed until February 2017. The primary outcomes were ischemic events and ischemic strokes; the secondary outcomes were all-cause mortality, major bleeding, and hemorrhagic strokes. The mean patient age was 73 years old, and 67% of the patients were male. Seventy-eight percent of the patients had hypertension, and dihydropyridine CCBs were used by 2693 (34%) patients (CCB group). The cumulative incidences of ischemic events and ischemic strokes at 4 years in the CCB and No-CCB groups were 5.9% vs. 5.2% and 5.6% vs. 4.8%, respectively. The adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) of the CCB group for ischemic events and ischemic strokes were 1.22 (0.95–1.57) and 1.32 (1.02–1.71), respectively; the adjusted HRs (95% CIs) of the CCB group for all-cause mortality, major bleeding, and hemorrhagic strokes were 0.85 (0.69–1.04), 1.12 (0.92–1.35), and 1.08 (0.62–1.88), respectively. Dihydropyridine CCB use by anticoagulated NVAF patients significantly increased ischemic strokes in a real-world setting. More... »

PAGES

1028-1036

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41440-022-00855-x

DOI

http://dx.doi.org/10.1038/s41440-022-00855-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1145633666

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35173285


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Fibrillation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium Channel Blockers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dihydropyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhagic Stroke", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ischemic Stroke", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan", 
            "Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakakibara", 
        "givenName": "Fumihiro", 
        "id": "sg:person.013672357213.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013672357213.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Okinawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.267625.2", 
          "name": [
            "Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Okinawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueda", 
        "givenName": "Shinichiro", 
        "id": "sg:person.012353001702.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012353001702.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan", 
            "Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Uchida", 
        "givenName": "Kazutaka", 
        "id": "sg:person.01075462233.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075462233.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan", 
            "Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kinjo", 
        "givenName": "Norito", 
        "id": "sg:person.014601567261.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014601567261.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arai", 
        "givenName": "Hideki", 
        "id": "sg:person.015616022431.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015616022431.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nezu", 
        "givenName": "Mari", 
        "id": "sg:person.012051525212.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012051525212.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morimoto", 
        "givenName": "Takeshi", 
        "id": "sg:person.011273662612.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011273662612.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/s41440-019-0284-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1120027740", 
          "https://doi.org/10.1038/s41440-019-0284-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-02-17", 
    "datePublishedReg": "2022-02-17", 
    "description": "Outside of clinical trials, the prophylactic effect of dihydropyridine calcium channel blockers (CCBs) on ischemic events in patients with nonvalvular atrial fibrillation (NVAF) has not been confirmed. We compared the effect of dihydropyridine CCBs on ischemic events in anticoagulated NVAF patients. We conducted a multicenter historical cohort study at 71 centers in Japan. The inclusion criterion was taking vitamin K antagonists for NVAF. The exclusion criteria were mechanical heart valves and a history of pulmonary thrombosis or deep vein thrombosis. Consecutive patients (N\u2009=\u20097826) were registered in February 2013 and were followed until February 2017. The primary outcomes were ischemic events and ischemic strokes; the secondary outcomes were all-cause mortality, major bleeding, and hemorrhagic strokes. The mean patient age was 73 years old, and 67% of the patients were male. Seventy-eight percent of the patients had hypertension, and dihydropyridine CCBs were used by 2693 (34%) patients (CCB group). The cumulative incidences of ischemic events and ischemic strokes at 4 years in the CCB and No-CCB groups were 5.9% vs. 5.2% and 5.6% vs. 4.8%, respectively. The adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) of the CCB group for ischemic events and ischemic strokes were 1.22 (0.95\u20131.57) and 1.32 (1.02\u20131.71), respectively; the adjusted HRs (95% CIs) of the CCB group for all-cause mortality, major bleeding, and hemorrhagic strokes were 0.85 (0.69\u20131.04), 1.12 (0.92\u20131.35), and 1.08 (0.62\u20131.88), respectively. Dihydropyridine CCB use by anticoagulated NVAF patients significantly increased ischemic strokes in a real-world setting.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41440-022-00855-x", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.9673290", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1313717", 
        "issn": [
          "0916-9636", 
          "1348-4214"
        ], 
        "name": "Hypertension Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "45"
      }
    ], 
    "keywords": [
      "dihydropyridine calcium channel blocker", 
      "calcium channel blockers", 
      "nonvalvular atrial fibrillation", 
      "ischemic events", 
      "ischemic stroke", 
      "hazard ratio", 
      "NVAF patients", 
      "major bleeding", 
      "cause mortality", 
      "CCB group", 
      "hemorrhagic stroke", 
      "atrial fibrillation", 
      "channel blockers", 
      "multicenter historical cohort study", 
      "vitamin K antagonists", 
      "mean patient age", 
      "adjusted hazard ratio", 
      "historical cohort study", 
      "deep vein thrombosis", 
      "vs. 5.2", 
      "vs. 4.8", 
      "K antagonists", 
      "CCB use", 
      "cohort study", 
      "pulmonary thrombosis", 
      "vein thrombosis", 
      "Secondary outcomes", 
      "patient age", 
      "cumulative incidence", 
      "consecutive patients", 
      "primary outcome", 
      "mechanical heart valves", 
      "prophylactic effect", 
      "clinical trials", 
      "inclusion criteria", 
      "exclusion criteria", 
      "patients", 
      "real-world setting", 
      "stroke", 
      "heart valves", 
      "bleeding", 
      "thrombosis", 
      "fibrillation", 
      "blockers", 
      "mortality", 
      "outcomes", 
      "group", 
      "hypertension", 
      "antagonist", 
      "years", 
      "incidence", 
      "trials", 
      "events", 
      "age", 
      "criteria", 
      "association", 
      "effect", 
      "percent", 
      "valve", 
      "setting", 
      "history", 
      "center", 
      "study", 
      "use", 
      "ratio", 
      "Japan"
    ], 
    "name": "Association between dihydropyridine calcium channel blockers and ischemic strokes in patients with nonvalvular atrial fibrillation", 
    "pagination": "1028-1036", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1145633666"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41440-022-00855-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35173285"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41440-022-00855-x", 
      "https://app.dimensions.ai/details/publication/pub.1145633666"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_956.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41440-022-00855-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41440-022-00855-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41440-022-00855-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41440-022-00855-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41440-022-00855-x'


 

This table displays all metadata directly associated to this object as RDF triples.

232 TRIPLES      21 PREDICATES      105 URIs      96 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41440-022-00855-x schema:about N2beff4ca27b340589936c22d3a98e953
2 N4d703bce86ba4604b11f1a227d8a93c9
3 N53f46b0442d84deb94fbc11e03c3a828
4 N59eca0cd055c49d9b813e510105ad30b
5 N648185de8c6a40428af0599216f2c9bd
6 N7162e015271b446783d912e480db1b23
7 N77d76e7d7e5241828c5c38e8447c5fa6
8 Na02c2c3fb6bd4ff9984f4dc2e7ee1f32
9 Nb229f60513754fd88108a2b4ca5e4363
10 Ne0248866573d41b9b79b7b367eec581c
11 Nf16cbf879ef3497caa5b2a32290429ef
12 Nfb4bd56556094a0fb50767ec98fb796d
13 Nfde4aae426f1489c81bcd6f3d1e036e9
14 anzsrc-for:11
15 anzsrc-for:1102
16 schema:author N8e923ea332364ab09b3b78ec6629df2d
17 schema:citation sg:pub.10.1038/s41440-019-0284-9
18 schema:datePublished 2022-02-17
19 schema:datePublishedReg 2022-02-17
20 schema:description Outside of clinical trials, the prophylactic effect of dihydropyridine calcium channel blockers (CCBs) on ischemic events in patients with nonvalvular atrial fibrillation (NVAF) has not been confirmed. We compared the effect of dihydropyridine CCBs on ischemic events in anticoagulated NVAF patients. We conducted a multicenter historical cohort study at 71 centers in Japan. The inclusion criterion was taking vitamin K antagonists for NVAF. The exclusion criteria were mechanical heart valves and a history of pulmonary thrombosis or deep vein thrombosis. Consecutive patients (N = 7826) were registered in February 2013 and were followed until February 2017. The primary outcomes were ischemic events and ischemic strokes; the secondary outcomes were all-cause mortality, major bleeding, and hemorrhagic strokes. The mean patient age was 73 years old, and 67% of the patients were male. Seventy-eight percent of the patients had hypertension, and dihydropyridine CCBs were used by 2693 (34%) patients (CCB group). The cumulative incidences of ischemic events and ischemic strokes at 4 years in the CCB and No-CCB groups were 5.9% vs. 5.2% and 5.6% vs. 4.8%, respectively. The adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) of the CCB group for ischemic events and ischemic strokes were 1.22 (0.95–1.57) and 1.32 (1.02–1.71), respectively; the adjusted HRs (95% CIs) of the CCB group for all-cause mortality, major bleeding, and hemorrhagic strokes were 0.85 (0.69–1.04), 1.12 (0.92–1.35), and 1.08 (0.62–1.88), respectively. Dihydropyridine CCB use by anticoagulated NVAF patients significantly increased ischemic strokes in a real-world setting.
21 schema:genre article
22 schema:isAccessibleForFree false
23 schema:isPartOf N158d28ccd5a24cd3b19dbe3206e39293
24 N73b429e537b24d3baac1d3f6fa43ac1c
25 sg:journal.1313717
26 schema:keywords CCB group
27 CCB use
28 Japan
29 K antagonists
30 NVAF patients
31 Secondary outcomes
32 adjusted hazard ratio
33 age
34 antagonist
35 association
36 atrial fibrillation
37 bleeding
38 blockers
39 calcium channel blockers
40 cause mortality
41 center
42 channel blockers
43 clinical trials
44 cohort study
45 consecutive patients
46 criteria
47 cumulative incidence
48 deep vein thrombosis
49 dihydropyridine calcium channel blocker
50 effect
51 events
52 exclusion criteria
53 fibrillation
54 group
55 hazard ratio
56 heart valves
57 hemorrhagic stroke
58 historical cohort study
59 history
60 hypertension
61 incidence
62 inclusion criteria
63 ischemic events
64 ischemic stroke
65 major bleeding
66 mean patient age
67 mechanical heart valves
68 mortality
69 multicenter historical cohort study
70 nonvalvular atrial fibrillation
71 outcomes
72 patient age
73 patients
74 percent
75 primary outcome
76 prophylactic effect
77 pulmonary thrombosis
78 ratio
79 real-world setting
80 setting
81 stroke
82 study
83 thrombosis
84 trials
85 use
86 valve
87 vein thrombosis
88 vitamin K antagonists
89 vs. 4.8
90 vs. 5.2
91 years
92 schema:name Association between dihydropyridine calcium channel blockers and ischemic strokes in patients with nonvalvular atrial fibrillation
93 schema:pagination 1028-1036
94 schema:productId N83039ac362f2458c8c95805e8947732f
95 Nc8d610a1abd74cf7b30dc8ae7dcfde9e
96 Ne437320a6c534622bff818754a3ae7f6
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1145633666
98 https://doi.org/10.1038/s41440-022-00855-x
99 schema:sdDatePublished 2022-10-01T06:50
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher N3ba6730439dd454f9a6ddc98e48d7a21
102 schema:url https://doi.org/10.1038/s41440-022-00855-x
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N158d28ccd5a24cd3b19dbe3206e39293 schema:volumeNumber 45
107 rdf:type schema:PublicationVolume
108 N2671c111441e43c9873b14bd83f496f1 rdf:first sg:person.011273662612.03
109 rdf:rest rdf:nil
110 N2beff4ca27b340589936c22d3a98e953 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Ischemic Stroke
112 rdf:type schema:DefinedTerm
113 N3ba6730439dd454f9a6ddc98e48d7a21 schema:name Springer Nature - SN SciGraph project
114 rdf:type schema:Organization
115 N4d703bce86ba4604b11f1a227d8a93c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Humans
117 rdf:type schema:DefinedTerm
118 N53f46b0442d84deb94fbc11e03c3a828 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Cohort Studies
120 rdf:type schema:DefinedTerm
121 N59eca0cd055c49d9b813e510105ad30b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Hemorrhagic Stroke
123 rdf:type schema:DefinedTerm
124 N61d72a5941474cdc8dc57efb51c1950c rdf:first sg:person.012051525212.91
125 rdf:rest N2671c111441e43c9873b14bd83f496f1
126 N648185de8c6a40428af0599216f2c9bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Dihydropyridines
128 rdf:type schema:DefinedTerm
129 N7162e015271b446783d912e480db1b23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Stroke
131 rdf:type schema:DefinedTerm
132 N73b429e537b24d3baac1d3f6fa43ac1c schema:issueNumber 6
133 rdf:type schema:PublicationIssue
134 N77d76e7d7e5241828c5c38e8447c5fa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Female
136 rdf:type schema:DefinedTerm
137 N80342c02ca7748b5b9784a6d007690c8 rdf:first sg:person.014601567261.41
138 rdf:rest Nfb23dfb7892b461d8da3c8ce68d850c8
139 N83039ac362f2458c8c95805e8947732f schema:name pubmed_id
140 schema:value 35173285
141 rdf:type schema:PropertyValue
142 N8e923ea332364ab09b3b78ec6629df2d rdf:first sg:person.013672357213.62
143 rdf:rest Nb3898415596040998ed0bf03fee16d5a
144 N9834da7730364d3fb0813c150ba2c6a2 rdf:first sg:person.01075462233.53
145 rdf:rest N80342c02ca7748b5b9784a6d007690c8
146 Na02c2c3fb6bd4ff9984f4dc2e7ee1f32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Hemorrhage
148 rdf:type schema:DefinedTerm
149 Nb229f60513754fd88108a2b4ca5e4363 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Atrial Fibrillation
151 rdf:type schema:DefinedTerm
152 Nb3898415596040998ed0bf03fee16d5a rdf:first sg:person.012353001702.96
153 rdf:rest N9834da7730364d3fb0813c150ba2c6a2
154 Nc8d610a1abd74cf7b30dc8ae7dcfde9e schema:name doi
155 schema:value 10.1038/s41440-022-00855-x
156 rdf:type schema:PropertyValue
157 Ne0248866573d41b9b79b7b367eec581c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Male
159 rdf:type schema:DefinedTerm
160 Ne437320a6c534622bff818754a3ae7f6 schema:name dimensions_id
161 schema:value pub.1145633666
162 rdf:type schema:PropertyValue
163 Nf16cbf879ef3497caa5b2a32290429ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Aged
165 rdf:type schema:DefinedTerm
166 Nfb23dfb7892b461d8da3c8ce68d850c8 rdf:first sg:person.015616022431.71
167 rdf:rest N61d72a5941474cdc8dc57efb51c1950c
168 Nfb4bd56556094a0fb50767ec98fb796d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Calcium Channel Blockers
170 rdf:type schema:DefinedTerm
171 Nfde4aae426f1489c81bcd6f3d1e036e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Anticoagulants
173 rdf:type schema:DefinedTerm
174 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
175 schema:name Medical and Health Sciences
176 rdf:type schema:DefinedTerm
177 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
178 schema:name Cardiorespiratory Medicine and Haematology
179 rdf:type schema:DefinedTerm
180 sg:grant.9673290 http://pending.schema.org/fundedItem sg:pub.10.1038/s41440-022-00855-x
181 rdf:type schema:MonetaryGrant
182 sg:journal.1313717 schema:issn 0916-9636
183 1348-4214
184 schema:name Hypertension Research
185 schema:publisher Springer Nature
186 rdf:type schema:Periodical
187 sg:person.01075462233.53 schema:affiliation grid-institutes:grid.272264.7
188 schema:familyName Uchida
189 schema:givenName Kazutaka
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075462233.53
191 rdf:type schema:Person
192 sg:person.011273662612.03 schema:affiliation grid-institutes:grid.272264.7
193 schema:familyName Morimoto
194 schema:givenName Takeshi
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011273662612.03
196 rdf:type schema:Person
197 sg:person.012051525212.91 schema:affiliation grid-institutes:grid.272264.7
198 schema:familyName Nezu
199 schema:givenName Mari
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012051525212.91
201 rdf:type schema:Person
202 sg:person.012353001702.96 schema:affiliation grid-institutes:grid.267625.2
203 schema:familyName Ueda
204 schema:givenName Shinichiro
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012353001702.96
206 rdf:type schema:Person
207 sg:person.013672357213.62 schema:affiliation grid-institutes:grid.272264.7
208 schema:familyName Sakakibara
209 schema:givenName Fumihiro
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013672357213.62
211 rdf:type schema:Person
212 sg:person.014601567261.41 schema:affiliation grid-institutes:grid.272264.7
213 schema:familyName Kinjo
214 schema:givenName Norito
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014601567261.41
216 rdf:type schema:Person
217 sg:person.015616022431.71 schema:affiliation grid-institutes:grid.272264.7
218 schema:familyName Arai
219 schema:givenName Hideki
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015616022431.71
221 rdf:type schema:Person
222 sg:pub.10.1038/s41440-019-0284-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1120027740
223 https://doi.org/10.1038/s41440-019-0284-9
224 rdf:type schema:CreativeWork
225 grid-institutes:grid.267625.2 schema:alternateName Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Okinawa, Japan
226 schema:name Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Okinawa, Japan
227 rdf:type schema:Organization
228 grid-institutes:grid.272264.7 schema:alternateName Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan
229 Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan
230 schema:name Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan
231 Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan
232 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...